Make your own free website on Tripod.com
Home | 2003 (1997-2003) Cover Shorty | Inside cover | News 11-04 | News 6-04 | Current stock holdings | Election results | Stock from the company | Stock givers /traders | Profit and loss | Balance sheet 2003 | Balance sheet 2000 | RE, S&U, bank stmts 2003 | RE, S&U, bank stmts 2000 | News & history first half 2004 | Dr. Peebles' story | News & history 2001 - 2003 | News & history 1997 - 2000 | Owners like Pfizer strategy | Wal-Mart strategy | Pedi-sales strategy | Celgene takeover of pediatric drugs strategy | Device maker strategy | Your choice for licensing strategies | Ballot | Expenses graph | Expense report 2003 | Goodwill report 2003 | Contacts
Prophy Research Corporation reports
Balance sheet 2000

6-7-04 draft Balance Sheet 2000  (2000 back to last report)
Prophy Research Corporation
Year end (Dec 31) 2000    (in dollars except number of shares)
Main Main Main Main
2000 changes changes changes changes Begin
year end during year end during year end during year end during year end
2000 2000 1999 1999 1998 1998 1997 1997 1996
Current assests
Cash 1,077 -25 1,102 225 877 -437 1,314 515 799
Other 0 0 0 0 0
Long term assets
Real assets 0 0 0 0 0
Patent aps* 235,010 14,450 220,560 16,320 204,240 16,940 187,300 44,000 143,300
Total assets 236,087 221,662 205,117 188,614 144,099
Liabilities 0 0   0   0   0
Net assets 236,087   221,662   205,117   188,614   144,099
Goodwill stock 235,010 14,450 220,560 16,320 204,240 16,940 187,300 44,000 143,300
Paid in capital stock 59,136 1,259 57,877 1,552 56,325 1,147 55,178 3,752 51,426
Total stock 294,146 278,437 260,565 242,478 194,726
Retained earnings (loss) -58,059 -1,284 -56,775 -1,327 -55,448 -1,584 -53,864 -3,237 -50,627
Stockholders' equity 236,087   221,662   205,117   188,614   144,099
Number of shares 25,530.36 1,570.90 23,959.46 1787.2 22,172.26 1808.7 20,363.56 4,775.20 15588.36
Equity/share 9.25 9.25 9.25 9.26 9.24
Cash assets/share 0.04 0.05 0.04 0.06 0.05
*Values assigned to patent rights**:  (These values are strictly fig newtons of my imagination.)
OptiDoseŽ 193,010 13,450 179,560 13,320 166,240 10,940 155,300 34,000 121,300
OsteoPat 42,000 1,000 41,000 3,000 38,000 6,000 32,000 10,000 22,000
Other 0 0 0 0 0 0 0 0 0
Total pat aps*** 235,010 14,450 220,560 16,320 204,240 16,940 187,300 44,000 143,300
**Prophy ownership of patent rights: All intellectual property (patents, trademarks, etc.) that I mention in our reports
have been ours (100% owned by the company) until this year. This spring I gave our guys in Switzerland 50%
of our Swiss patent. Heinz & Julia have done virtually everything that has been done in Switzerland to date, which
is our single best success story so far. (I'll get more into this arrangement in the "news".) Now let's get back to
notes about who owns what. The transfer from my ownership (the patent office grants ownership to the
applicant) to company ownership is by agreement, usually explicit. For example, in our original incorporation
I give the OptiDose rights, and in the Osteo patent application I list Prophy as the assignee. However, this does not
give our company clear title. This is fine in most situations, but it would be cleaner if we went ahead and transferred
title to the company, at least for the valuable pieces of property. I was getting the paper work (about 5   
pages) and cash (about $65) ready for OptiDose (U.S. patent rights), when the stupid 
lost check issue came up. I'll get back on that. I'll start gathering paperwork for the U.S. trademark, and see what
the situation is for the remainder of the Swiss patent rights.
*** The total patent aps had a slight mistake on the 1996 balance sheet. It showed $143, 330 ($30 too much). That came from
two old mistakes when I used to total the stock clubs by hand instead of Excel. The PD club showed 37 shares instead of the
correct total of 36, and the NHSC club showed 241 shares, not the correct 245. The net effect was 3 extra shares at $10.

On to the next page (more financials - the exciting "retained earnings", "sources and uses of funds", and even a "bank statement")